CGT
HAE icon

Capital Guardian Trust’s Haemonetics HAE Stock Holding History

Capital Guardian Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-55
Closed -$2K – 576
2014
Q3 		$2K Buy
+55
New +$1.96K ﹤0.01% 593

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Capital Guardian Trust's HAE Position: Q4 2014 in Review

Capital Guardian Trust sold out of Haemonetics (HAE) in Q4 2014, closing a stake of 55 shares — an estimated $2K sold.

Capital Guardian Trust first reported a position in HAE in Q3 2014 and held it in 1 quarter. The position peaked at $2K in Q3 2014. 172 funds tracked by Wall St. Rank hold HAE as of Q4 2014.

  • Capital Guardian Trust reported no remaining Haemonetics position as of Q4 2014 after selling out during the quarter.
  • Capital Guardian Trust sold 55 Haemonetics shares in Q4 2014, an estimated $2K.
  • Capital Guardian Trust first reported a position in Haemonetics in Q3 2014 and held it in 1 quarter.
  • Capital Guardian Trust's Haemonetics position peaked at $2K in Q3 2014.
  • 172 funds tracked by Wall St. Rank held Haemonetics as of Q4 2014.

Based on Capital Guardian Trust's 13F filing for Q4 2014, filed 13 Feb 2015.